BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, Qin Y, Liu X, Li S, Cai J, Zhong J, Yang X. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience 2019;8:giz058. [PMID: 31149718 DOI: 10.1093/gigascience/giz058] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 30.5] [Reference Citation Analysis]
Number Citing Articles
1 Zuo K, Fang C, Fu Y, Liu Z, Liu Y, Liu L, Wang Y, Wang H, Yin X, Liu X, Li J, Zhong J, Chen M, Yang X, Xu L. The Impact of Sleep Disturbance on Gut Microbiota, Atrial Substrate, and Atrial Fibrillation Inducibility in Mice: A Multi-Omics Analysis. Metabolites 2022;12:1144. [DOI: 10.3390/metabo12111144] [Reference Citation Analysis]
2 Liu T, Hu X, Chen P, Zhang R, Zhang S, Chang W, Wang J, Wang S. Effect of partially hydrolyzed guar gum on the composition and metabolic function of the intestinal flora of healthy mice. Journal of Food Biochemistry 2022. [DOI: 10.1111/jfbc.14508] [Reference Citation Analysis]
3 Wang L, Wang S, Zhang Q, He C, Fu C, Wei Q. The role of the gut microbiota in health and cardiovascular diseases. Mol Biomed 2022;3:30. [PMID: 36219347 DOI: 10.1186/s43556-022-00091-2] [Reference Citation Analysis]
4 Fang C, Zuo K, Fu Y, Zhu X, Li J, Zhong J, Xu L, Yang X. Aggravated Gut Microbiota and Metabolomic Imbalances Are Associated with Hypertension Patients Comorbid with Atrial Fibrillation. Biomolecules 2022;12:1445. [PMID: 36291654 DOI: 10.3390/biom12101445] [Reference Citation Analysis]
5 Kong B, Fu H, Xiao Z, Zhou Y, Shuai W, Huang H. Gut microbiota dysbiosis induced by a high-fat diet increases susceptibility to atrial fibrillation. Can J Cardiol 2022:S0828-282X(22)00786-3. [PMID: 36084771 DOI: 10.1016/j.cjca.2022.08.231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhou Y, Suo W, Zhang X, Lv J, Liu Z, Liu R. Roles and mechanisms of quercetin on cardiac arrhythmia: A review. Biomedicine & Pharmacotherapy 2022;153:113447. [DOI: 10.1016/j.biopha.2022.113447] [Reference Citation Analysis]
7 Zhang Y, Zhang X, Chen D, Lu J, Gong Q, Fang J, Jiang J. Causal associations between gut microbiome and cardiovascular disease: A Mendelian randomization study. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.971376] [Reference Citation Analysis]
8 Huang Z, Zhan M, Cheng G, Lin R, Zhai X, Zheng H, Wang Q, Yu Y, Xu Z. IHNV Infection Induces Strong Mucosal Immunity and Changes of Microbiota in Trout Intestine. Viruses 2022;14:1838. [PMID: 36016461 DOI: 10.3390/v14081838] [Reference Citation Analysis]
9 Zuo K, Li J, Fang C, Zhong J, Xu L, Yang X. Alterations of gut viral signals in atrial fibrillation: complex linkage with gut bacteriome. Aging (Albany NY) 2022;14. [PMID: 35985693 DOI: 10.18632/aging.204222] [Reference Citation Analysis]
10 Fang C, Zuo K, Jiao K, Zhu X, Fu Y, Zhong J, Xu L, Yang X. PAGln, an Atrial Fibrillation-Linked Gut Microbial Metabolite, Acts as a Promoter of Atrial Myocyte Injury. Biomolecules 2022;12:1120. [DOI: 10.3390/biom12081120] [Reference Citation Analysis]
11 Lu C, Liu C, Mei D, Yu M, Bai J, Bao X, Wang M, Fu K, Yi X, Ge W, Shen J, Peng Y, Xu W. Comprehensive metabolomic characterization of atrial fibrillation. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.911845] [Reference Citation Analysis]
12 Koc F, Sugrue I, Murphy K, Renzetti S, Noort M, Ross RP, Stanton C. The microbiome modulating potential of superheated steam (SHS) treatment of dietary fibres. Innovative Food Science & Emerging Technologies 2022;80:103082. [DOI: 10.1016/j.ifset.2022.103082] [Reference Citation Analysis]
13 Luo Y, Zhang Y, Han X, Yuan Y, Zhou Y, Gao Y, Yu H, Zhang J, Shi Y, Duan Y, Zhao X, Yan S, Hao H, Dai C, Zhao S, Shi J, Li W, Zhang S, Xu W, Fang N, Gong Y, Li Y. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis. EBioMedicine 2022;82:104087. [PMID: 35797768 DOI: 10.1016/j.ebiom.2022.104087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zuo K, Fang C, Liu Z, Fu Y, Liu Y, Liu L, Wang Y, Yin X, Liu X, Li J, Zhong J, Chen M, Xu L, Yang X. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci 2022;18:4219-32. [PMID: 35844801 DOI: 10.7150/ijbs.70644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lu D, Zou X, Zhang H. The Relationship Between Atrial Fibrillation and Intestinal Flora With Its Metabolites. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.948755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Yang Z, Yu R, Deng W, Wang W. Roles of 21 Genera of Human Gut Microbiota in Barrett's Esophagus Risk: A Mendelian Randomization Study. Front Genet 2022;13:894900. [PMID: 35754845 DOI: 10.3389/fgene.2022.894900] [Reference Citation Analysis]
17 Liu Y, Dong J, Zhang Z, Liu Y, Wang Y. How Brain Infarction Links With the Microbiota-Gut-Brain Axis: Hints From Studies Focusing on the Risk Factors for Ischemic Stroke. Front Neurosci 2022;16:877937. [PMID: 35685776 DOI: 10.3389/fnins.2022.877937] [Reference Citation Analysis]
18 Ajoolabady A, Nattel S, Lip GY, Ren J. Inflammasome Signaling in Atrial Fibrillation. Journal of the American College of Cardiology 2022;79:2349-66. [DOI: 10.1016/j.jacc.2022.03.379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gu S, Xie Q, Chen C, Liu C, Xue W. Gut Microbial Signatures Associated with Peanut Allergy in a BALB/c Mouse Model. Foods 2022;11:1395. [DOI: 10.3390/foods11101395] [Reference Citation Analysis]
20 Fang C, Zuo K, Zhang W, Zhong J, Li J, Xu L, Yang X, Scicchitano P. Association between Gut Microbiota Dysbiosis and the CHA2DS2-VASc Score in Atrial Fibrillation Patients. International Journal of Clinical Practice 2022;2022:1-10. [DOI: 10.1155/2022/7942605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines 2022;10:948. [DOI: 10.3390/biomedicines10050948] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Wang L, Zhang Y, Guo X, Gong L, Dong B. Beneficial Alteration in Growth Performance, Immune Status, and Intestinal Microbiota by Supplementation of Activated Charcoal-Herb Extractum Complex in Broilers. Front Microbiol 2022;13:856634. [DOI: 10.3389/fmicb.2022.856634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, Wang S, Xin H. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr 2022;:e0107721. [PMID: 35384710 DOI: 10.1128/spectrum.01077-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Fang C, Zuo K, Fu Y, Li J, Wang H, Xu L, Yang X. Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis. Front Cardiovasc Med 2022;9:832092. [DOI: 10.3389/fcvm.2022.832092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
25 An N, Zhang G, Li Y, Yuan C, Yang F, Zhang L, Gao Y, Xing Y. Promising Antioxidative Effect of Berberine in Cardiovascular Diseases. Front Pharmacol 2022;13:865353. [DOI: 10.3389/fphar.2022.865353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Choroszy M, Sobieszczańska B, Litwinowicz K, Łaczmański Ł, Chmielarz M, Walczuk U, Roleder T, Radziejewska J, Wawrzyńska M. Co-toxicity of Endotoxin and Indoxyl Sulfate, Gut-Derived Bacterial Metabolites, to Vascular Endothelial Cells in Coronary Arterial Disease Accompanied by Gut Dysbiosis. Nutrients 2022;14:424. [PMID: 35276782 DOI: 10.3390/nu14030424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Alam MJ, Puppala V, Uppulapu SK, Das B, Banerjee SK. Human microbiome and cardiovascular diseases. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.012] [Reference Citation Analysis]
28 Cao R, Zeng Y, Li S, Xue P, Li M. Short-Chain Fatty Acids-A Healthy Bus between Gut Microbiota and Organs beyond the Gut. ABB 2022;13:362-387. [DOI: 10.4236/abb.2022.139024] [Reference Citation Analysis]
29 Zor’kina M, Skirdenko Y, Gorbenko A, Nikolaev N, Andreev K. Atrial fibrillation and the gut microbiota: is there a link? Profil med 2022;25:110. [DOI: 10.17116/profmed202225051110] [Reference Citation Analysis]
30 Xu DJ, Wang KC, Yuan LB, Li HF, Xu YY, Wei LY, Chen L, Jin KK, Lin QQ. Compositional and functional alterations of gut microbiota in patients with stroke. Nutr Metab Cardiovasc Dis 2021;31:3434-48. [PMID: 34666915 DOI: 10.1016/j.numecd.2021.08.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
31 Li N, Durgan DJ, Wehrens XHT. Gut microbiota - a key regulator of aging-associated atrial fibrillation? Cardiovasc Res 2021:cvab346. [PMID: 34849621 DOI: 10.1093/cvr/cvab346] [Reference Citation Analysis]
32 Roth W, Mohamadzadeh M. Vitamin B12 and gut-brain homeostasis in the pathophysiology of ischemic stroke. EBioMedicine 2021;73:103676. [PMID: 34749301 DOI: 10.1016/j.ebiom.2021.103676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
33 Wang S, Guo C, Xing Z, Li M, Yang H, Zhang Y, Ren F, Chen L, Mi S. Dietary Intervention With α-Amylase Inhibitor in White Kidney Beans Added Yogurt Modulated Gut Microbiota to Adjust Blood Glucose in Mice. Front Nutr 2021;8:664976. [PMID: 34712684 DOI: 10.3389/fnut.2021.664976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Kassan A, Ait-Aissa K, Kassan M. Hypothalamic miR-204 Induces Alteration of Heart Electrophysiology and Neurogenic Hypertension by Regulating the Sympathetic Nerve Activity: Potential Role of Microbiota. Cureus 2021;13:e18783. [PMID: 34692262 DOI: 10.7759/cureus.18783] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sharma V, Sharma V, Shahjouei S, Li J, Chaudhary D, Khan A, Wolk DM, Zand R, Abedi V. At the Intersection of Gut Microbiome and Stroke: A Systematic Review of the Literature. Front Neurol 2021;12:729399. [PMID: 34630304 DOI: 10.3389/fneur.2021.729399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
36 Gawałko M, Agbaedeng TA, Saljic A, Müller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, Schotten U, Crijns HJGM, Kalman JM, Sanders P, Nattel S, Dobrev D, Linz D. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res 2021:cvab292. [PMID: 34550344 DOI: 10.1093/cvr/cvab292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
37 Baranwal G, Pilla R, Goodlett BL, Coleman AK, Arenaz CM, Jayaraman A, Rutkowski JM, Alaniz RC, Mitchell BM. Common Metabolites in Two Different Hypertensive Mouse Models: A Serum and Urine Metabolome Study. Biomolecules 2021;11:1387. [PMID: 34572600 DOI: 10.3390/biom11091387] [Reference Citation Analysis]
38 Liu L, Su J, Li R, Luo F. Changes in Intestinal Flora Structure and Metabolites Are Associated With Myocardial Fibrosis in Patients With Persistent Atrial Fibrillation. Front Nutr 2021;8:702085. [PMID: 34497820 DOI: 10.3389/fnut.2021.702085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Cao M, Peng Y, Lu Y, Zou Z, Chen J, Bottino R, Knoll M, Zhang H, Lin S, Pu Z, Sun L, Fang Z, Qiu C, Dai Y, Cai Z, Mou L. Controls of Hyperglycemia Improves Dysregulated Microbiota in Diabetic Mice. Transplantation 2021;105:1980-8. [PMID: 34416751 DOI: 10.1097/TP.0000000000003603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhang J, Zuo K, Fang C, Yin X, Liu X, Zhong J, Li K, Li J, Xu L, Yang X. Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation. BMC Genomics 2021;22:634. [PMID: 34465304 DOI: 10.1186/s12864-021-07944-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
41 Kaburova AN, Drapkina OM, Yudin SM, Koretsky SN, Makarov VV, Pokrovskaya MS, Kraevoy SA, Shoybonov BB, Efimova IA. Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction. Cardiovasc Ther Prev 2021;20:2834. [DOI: 10.15829/1728-8800-2021-2834] [Reference Citation Analysis]
42 Hu C, Wang P, Yang Y, Li J, Jiao X, Yu H, Wei Y, Li J, Qin Y. Chronic Intermittent Hypoxia Participates in the Pathogenesis of Atherosclerosis and Perturbs the Formation of Intestinal Microbiota. Front Cell Infect Microbiol 2021;11:560201. [PMID: 34277461 DOI: 10.3389/fcimb.2021.560201] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
43 Cheng WL, Li SJ, Lee TI, Lee TW, Chung CC, Kao YH, Chen YJ. Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis. Biomedicines 2021;9:728. [PMID: 34201938 DOI: 10.3390/biomedicines9070728] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
44 Mehta NK, Strickling J, Mark E, Swinehart S, Puthumana J, Lavie CJ, Haines DE, Franklin BA. Beyond cardioversion, ablation and pharmacotherapies: Risk factors, lifestyle change and behavioral counseling strategies in the prevention and treatment of atrial fibrillation. Prog Cardiovasc Dis 2021;66:2-9. [PMID: 34023354 DOI: 10.1016/j.pcad.2021.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
45 Kumar D, Mukherjee SS, Chakraborty R, Roy RR, Pandey A, Patra S, Dey S. The emerging role of gut microbiota in cardiovascular diseases. Indian Heart J 2021;73:264-72. [PMID: 34154741 DOI: 10.1016/j.ihj.2021.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
46 Rodríguez-Sojo MJ, Ruiz-Malagón AJ, Rodríguez-Cabezas ME, Gálvez J, Rodríguez-Nogales A. Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights. Nutrients 2021;13:1016. [PMID: 33801082 DOI: 10.3390/nu13031016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Doran S, Arif M, Lam S, Bayraktar A, Turkez H, Uhlen M, Boren J, Mardinoglu A. Multi-omics approaches for revealing the complexity of cardiovascular disease. Brief Bioinform 2021:bbab061. [PMID: 33725119 DOI: 10.1093/bib/bbab061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
48 Lin YT, Lin TY, Hung SC, Liu PY, Hung WC, Tsai WC, Tsai YC, Delicano RA, Chuang YS, Kuo MC, Chiu YW, Wu PH. Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers. J Pers Med 2021;11:198. [PMID: 33809103 DOI: 10.3390/jpm11030198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tanase DM, Leustean AM, Gosav EM. Implications of microbiota in the pathogenesis of diabetes mellitus and cardiovascular disease. Gut Microbiota in Neurologic and Visceral Diseases 2021. [DOI: 10.1016/b978-0-12-821039-0.00005-8] [Reference Citation Analysis]
50 Wu PH, Liu PY, Chiu YW, Hung WC, Lin YT, Lin TY, Hung SC, Delicano RA, Kuo MC, Wu CY. Comparative Gut Microbiome Differences between Ferric Citrate and Calcium Carbonate Phosphate Binders in Patients with End-Stage Kidney Disease. Microorganisms 2020;8:E2040. [PMID: 33419265 DOI: 10.3390/microorganisms8122040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
51 Bowerman KL, Rehman SF, Vaughan A, Lachner N, Budden KF, Kim RY, Wood DLA, Gellatly SL, Shukla SD, Wood LG, Yang IA, Wark PA, Hugenholtz P, Hansbro PM. Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease. Nat Commun 2020;11:5886. [PMID: 33208745 DOI: 10.1038/s41467-020-19701-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 33.5] [Reference Citation Analysis]
52 Li J, Zuo K, Zhang J, Hu C, Wang P, Jiao J, Liu Z, Yin X, Liu X, Li K, Yang X. Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation. J Cell Mol Med 2020;24:13356-69. [PMID: 33058365 DOI: 10.1111/jcmm.15959] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
53 Cobo F, Foronda C, Pérez-Carrasco V, Martin-Hita L, García-Salcedo JA, Navarro-Marí JM. First description of abdominal infection due to Alistipes onderdonkii. Anaerobe 2020;66:102283. [PMID: 33022383 DOI: 10.1016/j.anaerobe.2020.102283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L, Cai J. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell 2021;12:346-59. [PMID: 32989686 DOI: 10.1007/s13238-020-00785-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
55 Zhou W, Cheng Y, Zhu P, Nasser MI, Zhang X, Zhao M. Implication of Gut Microbiota in Cardiovascular Diseases. Oxid Med Cell Longev 2020;2020:5394096. [PMID: 33062141 DOI: 10.1155/2020/5394096] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
56 Zhao Y, Wang Z. Gut microbiome and cardiovascular disease. Curr Opin Cardiol 2020;35:207-18. [PMID: 32068612 DOI: 10.1097/HCO.0000000000000720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
57 Zuo K, Liu X, Wang P, Jiao J, Han C, Liu Z, Yin X, Li J, Yang X. Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients. BMC Genomics 2020;21:526. [PMID: 32731896 DOI: 10.1186/s12864-020-06944-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
58 Tabata T, Yamashita T, Hosomi K, Park J, Hayashi T, Yoshida N, Saito Y, Fukuzawa K, Konishi K, Murakami H, Kawashima H, Mizuguchi K, Miyachi M, Kunisawa J, Hirata KI. Gut microbial composition in patients with atrial fibrillation: effects of diet and drugs. Heart Vessels 2021;36:105-14. [PMID: 32683492 DOI: 10.1007/s00380-020-01669-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
59 Parker BJ, Wearsch PA, Veloo ACM, Rodriguez-Palacios A. The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol 2020;11:906. [PMID: 32582143 DOI: 10.3389/fimmu.2020.00906] [Cited by in Crossref: 281] [Cited by in F6Publishing: 310] [Article Influence: 140.5] [Reference Citation Analysis]
60 Li J, Yang X, Zhou X, Cai J. The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxid Redox Signal 2021;34:811-30. [PMID: 32316741 DOI: 10.1089/ars.2020.8104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
61 Tonomura S, Ihara M, Friedland RP. Microbiota in cerebrovascular disease: A key player and future therapeutic target. J Cereb Blood Flow Metab 2020;40:1368-80. [PMID: 32312168 DOI: 10.1177/0271678X20918031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
62 Zuo K, Yin X, Li K, Zhang J, Wang P, Jiao J, Liu Z, Liu X, Liu J, Li J, Yang X. Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis. mSphere 2020;5:e00071-20. [PMID: 32188747 DOI: 10.1128/mSphere.00071-20] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
63 Zuo K, Li J, Zhang J, Wang P, Jiao J, Liu Z, Yin X, Liu X, Li K, Yang X. Shifts in gut microbiome and metabolome are associated with risk of recurrent atrial fibrillation.. [DOI: 10.1101/2020.01.26.920587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Zuo K, Li J, Wang P, Liu Y, Liu Z, Yin X, Liu X, Yang X. Duration of Persistent Atrial Fibrillation Is Associated with Alterations in Human Gut Microbiota and Metabolic Phenotypes. mSystems 2019;4:e00422-19. [PMID: 31822598 DOI: 10.1128/mSystems.00422-19] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
65 Li BY, Xu XY, Gan RY, Sun QC, Meng JM, Shang A, Mao QQ, Li HB. Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products. Foods. 2019;8. [PMID: 31557941 DOI: 10.3390/foods8100440] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 15.0] [Reference Citation Analysis]